文献速递鼻科

非过敏性鼻炎患者局部特异性免疫球蛋白E的系统综述

Local specific Immunoglobulin E among patients with nonallergic rhinitis: a systematic review.
PubMed 文献 · Rhinology · 2019-01-01

该系统综述检索Embase和Medline至2017年6月,纳入21项研究共648例非过敏性鼻炎患者,采用加权概率(95%CI)进行单比例Meta分析,发现鼻分泌物中可检测到nspIgE的加权比例为10.2%(7.4-13.4%),且无过敏史者显著低于有过敏史者(0%(0-3.1%) vs 19.8%(14.5-25.6%),p<0.01)。结论提示有过敏史的非过敏性鼻炎患者应进一步评估局部鼻过敏。

要点

  • 非过敏性鼻炎患者鼻分泌物中nspIgE检出加权比例为10.2%(95%CI 7.4-13.4%)
  • 有过敏史者nspIgE检出率19.8%,显著高于无过敏史者的0%(p<0.01)
  • 有过敏史的非过敏性鼻炎患者建议进一步过敏学评估以确认局部过敏性鼻炎

核心结论

  • 有过敏史的非过敏性鼻炎患者提示存在鼻局部特异性IgE,应进一步过敏学评估以确认局部鼻过敏并考虑免疫治疗等过敏治疗获益。

研究设计与样本

  • 系统综述,检索Embase(1947年起)和Medline(1946年起)至2017年6月6日。
  • 纳入21项原始研究,共648例非过敏性鼻炎患者。
  • 采用单比例Meta分析计算加权概率%(95%CI),并探索研究间异质性。

主要发现

  • 鼻分泌物中nspIgE检出加权比例为10.2%(95%CI 7.4-13.4%)。
  • 无过敏史者nspIgE检出为0%(95%CI 0-3.1%),有过敏史者为19.8%(95%CI 14.5-25.6%),组间p<0.01。
  • 人群定义部分解释了研究间变异性。

关键数值与推荐

  • nspIgE检测方法包括鼻分泌物、上皮黏膜取样、组织活检或原位试验。
  • Meta分析仅针对鼻分泌物检测研究进行。

临床怎么用

  • 对非过敏性鼻炎伴过敏史的患者,应考虑检测鼻局部特异性IgE以识别局部过敏性鼻炎。
  • 确诊局部过敏性鼻炎者可受益于免疫治疗等过敏治疗。

局限性

  • 系统综述检索截止2017年6月6日,未纳入此后研究。
  • Meta分析仅基于鼻分泌物检测研究,其他检测方法未汇总。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Allergen specific immunoglobulin can be present in the nasal mucosa of patients with non-allergic rhinitis (NAR). This condition is defined as local allergic rhinitis. However, the reported presence of nasal specific immunoglobulin E (nspIgE) among NAR is variable. The aim of this review was to summarize the studies which reported the presence of nspIgE among patients diagnosed as NAR. METHODS: Embase (1947- ) and Medline (1946-) were searched until 6th June 2017. A search strategy was utilized to identify studies on nspIgE among patients with NAR. The target population was patients with symptoms of rhinitis, but negative systemic allergen sensitization. Studies with original data on detectable nspIgE among the NAR population were included. Meta-analysis of single proportions as a weighted probability %(95%CI) was performed. Heterogeneity was explored amongst studies. RESULTS: A search strategy returned 2286 studies and 21 were included. These studies involved 648 participants with NAR. NspIgE was detected using either; 1. nasal secretions, 2. epithelial mucosa sampling, 3. tissue biopsies or 4. In-situ tests. Metaanalysis was performed on studies with nasal secretions. The weighted proportion of detectable nspIgE in nasal secretions within patients with NAR was 10.2 (7.4-13.4) %. Population definitions partly explained variability. Detection of nspIgE was lower in patients without a history suggestive of allergy compared to those with a positive allergic history (0 (0-3.1) % v 19.8 (14.5-25.6) %, p<0.01). CONCLUSION: NAR with positive allergy history suggests presence of nspIgE. These patients warrant further allergology evaluation to confirm localized nasal allergy, as they benefit from allergy therapy such as immunotherapy.

来源:Rhinology,查看原文。版权归原作者所有。

引用

  1. Hamizan AW, Rimmer J, Husain S, et al. Local specific Immunoglobulin E among patients with nonallergic rhinitis: a systematic review. Rhinology. 2019. PMID: 30219822. doi:10.4193/Rhin18.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。